Sensei Biotherapeutics, Inc. SNSE
Set alert
13.85 USD 0.00 0.00%
At close · Jun 15
14.01 +0.16 +1.16%
After hours · Jun 15, 4:00 PM ET
13.76 Day range 16.52
0.384 52-week range 1.94
- YTD
- +29.80%
- 1 year
- +85.16%
- Open
- 15.21
- Prev close
- 13.85
- Mkt cap
- 11.37M
- Vol
- 219.47K
- Avg vol
- 460.67K
- EPS
- -1.19
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.76
- High
- 16.52
- Forward P/E
- -0.40
- Beta
- 0.06
- Short ratio
- 0.29
- Inst. own
- 8.81%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 0.5072
- 200-d avg
- 0.747255
- 1y target
- 4.13
Financial health
Altman Z-Score
-4.61 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.6×
FY 2018 5y median -11.3× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.7×
FY 2018 5y median 6.4× FY 2025
P/FCF -0.7×
FY 2018 5y median -12.0× FY 2025
EV/EBITDA -0.3×
FY 2018 5y median -10.7× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -152.2%
FY 2018 5y median -8.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -113.4%
FY 2018 5y median -52.5% FY 2025
ROIC -110.9%
FY 2018 5y median -52.1% FY 2025
ROA -92.1%
FY 2018 5y median -45.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 29.6%
FY 2018 FY 2025
EPS (diluted) -1293.3%
FY 2018 FY 2025
Free Cash Flow 17.5%
FY 2018 FY 2025
Financial Health
Current Ratio 5.1×
FY 2018 5y median 11.9× FY 2025
Quick Ratio 5.1×
FY 2018 5y median 11.9× FY 2025
Debt / Equity 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2018 5y median 0.2× FY 2025
Interest Coverage -697×
FY 2018 5y median -257× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31